Evotec SE
- EVO
- NASDAQ
- Drug Manufacturers - Specialty & Generic
- Drug Discovery Services
$1.42
Today +2.90%Quote Oct 19, 2026, 03:24 PM UTC
−17.37%over the last month
Max drawdown −21.1%From 1-month high −19.3%3 months −30.3%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$252.4M
Quote Oct 19
Next earnings
Nov 5
Expected, not confirmed
Analyst target
$3.00
+111.3% from here
Floor
$1.40
1.6% below price
Where the price sits
7 analysts
Analyst range, low to high
$2.00$4.00
- Price $1.42
- Resistance $1.46
- Consensus $3.00
The price is just above its floor. Analysts' average target sits about 111% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about EVOPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Drug Manufacturers - Specialty & Generic
Employees
4,553